Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Allon Therapeutics Inc NPCUF

Healthcare Biotechnology
Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).


GREY:NPCUF - Post by User

Allon Therapeutics Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by diadon1945on Dec 14, 2012 7:41pm
262 Views
Post# 20733538

RE: RE: : Allon Raising $50 Million

RE: RE: : Allon Raising $50 Million

I'm not worried about the sale of shares to finance the sales of Daveunatide in the US. And I would be pleased if some Big Pharma bought some shares as part of a partnership that also included upfront,milestone and royalty payments(and possibly co-marketing in North America).

We all hope that there is good news...it would be nice if it comes before Christmas...but they may want to put it out at the latest possible time in December to be part of the usual January upswing. If there is good news about the American's avoiding the Fiscal Cliff there could also be a Christmas rally!

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities